Understanding DaVita HealthCare Partners Inc (DVA): A Quantitative Research Analysis
This article is an educational StockValueFinder review of DaVita HealthCare Partners Inc (DVA). The purpose of this research is to provide a detailed breakdown of specific financial metrics to help readers understand how fundamental analysis and technical signals are evaluated in a professional context. This is not a recommendation to buy or sell, but rather a guide on how to interpret the data points that define a company's financial profile.
DaVita HealthCare Partners Inc (DVA) operates within the Healthcare sector, specifically in the Medical Care Facilities industry. As of the most recent data provided, the stock is trading at $183.64. In the complex ecosystem of the healthcare market, where information is often dispersed and economic forecasting is subject to constant uncertainty, understanding the distinction between price movement and fundamental health is critical for any disciplined researcher.
The StockValueFinder Score and Rating
Every research report begins with an overview of how a company performs against a standardized set of quality screens. For DaVita HealthCare Partners Inc, the StockValueFinder score is 33%. Based on this quantitative assessment, the current rating is AVOID.
It is important to understand what a score represents. The StockValueFinder score is a composite metric that aggregates various tests, including profitability, debt management, valuation, and earnings consistency. A score of 33% indicates that the company has failed a majority of the fundamental quality screens used by this system. In professional research, a low score often suggests that while a stock may be active in the market, it lacks the specific combination of efficiency, safety, and value required to meet high-quality institutional benchmarks. The "AVOID" rating is a direct consequence of this low score, signaling that the current fundamental data does not align with the criteria for a high-conviction investment.
EPS Strength and Consistency
Earnings Per Share (EPS) is a foundational metric in equity research. It represents the portion of a company's profit allocated to each outstanding share of common stock. For investors, EPS consistency is vital because it demonstrates a company's ability to generate predictable returns for its shareholders over time. High volatility in EPS can indicate an unstable business model or susceptibility to unpredictable market shifts.
Regarding DaVita HealthCare Partners Inc, the system recorded that the EPS test was PASSED. While the specific historical EPS values and exact dollar amounts were not supplied in this data set, a "passed" result indicates that the company's earnings per share met the internal requirements for consistency and stability.
To learn how to evaluate other stocks, consider this example: Imagine Company A has an EPS of $2.00 every year for five years. This shows high predictability. Conversely, imagine Company B has an EPS of $5.00 one year, $0.10 the next, and $4.00 the year after. Even if Company B's average EPS is higher, its lack of consistency makes it much harder to forecast, which increases uncertainty for a researcher.
ROIC and Capital Efficiency
Return on Invested Capital (ROIC) is a critical metric used to measure how effectively a company uses the money it has raised through debt and equity to generate profits. It is often considered one of the most important indicators of a "moat" or a competitive advantage.
For DVA, the actual ROIC is 5.32%. The StockValueFinder system generally prefers an ROIC of 10% or higher. Because 5.32% falls below this threshold, the ROIC test was marked as DID NOT PASS. This suggests that DaVita may be struggling to generate high levels of profit relative to the total capital deployed in its operations.
To understand why this matters, consider a simple comparison: A company with a 15% ROIC is using its capital much more efficiently than a company with a 4% ROIC. If a company has a low ROIC, it means that for every dollar they invest back into the business (such as new medical facilities or equipment), they are receiving a relatively small return. This can make it difficult for a company to grow organically without constantly seeking more external capital.
Interest Coverage and Financial Safety
Interest coverage is a solvency ratio that measures how easily a company can pay interest on its outstanding debt using its operating income. It acts as a safety margin; the higher the coverage, the less likely a company is to face financial distress if its earnings temporarily decline.
In the case of DaVita HealthCare Partners Inc, the system recorded that the interest coverage test DID NOT PASS. While the exact coverage ratio was not provided, we know it failed to meet the StockValueFinder preference for an interest coverage ratio of 6 or higher.
To visualize this risk, consider two hypothetical companies
– **Company X** has an interest coverage of 8x. This means its earnings are eight times larger than its interest obligations, providing a significant cushion against economic downturns. – **Company Y** has an interest coverage of 2x. This means its earnings only cover the interest twice over. If profits drop even slightly, Company Y may struggle to meet its debt obligations.
When a company fails this test, it signals that a larger portion of its operating cash flow is being consumed by debt servicing, which increases the overall risk profile of the stock.
Debt Payback and Balance Sheet Discipline
Debt payback refers to the estimated number of years it would take for a company to pay off its total debt using its current earnings. This metric provides insight into the long-term sustainability of a company's leverage.
The supplied data shows that DaVita’s debt payback is 7.76 years. StockValueFinder prefers a debt payback period of 3 years or less. Consequently, the debt payback test DID NOT PASS. A payback period of nearly eight years suggests a heavy debt burden that will take a significant amount of time to resolve through standard operations.
For educational purposes, compare these two scenarios
– An attractive scenario is a company with a 1.5-year debt payback. This company can clear its obligations quickly and redirect cash toward growth or dividends. – A risky scenario is a company with a 7-year debt payback. Such a company is heavily reliant on maintaining steady earnings over a long horizon to manage its liabilities, leaving little room for error.
P/E Ratio and Valuation Discipline
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's current share price to its per-share earnings. It helps investors understand how much they are paying for every dollar of profit the company generates.
For DVA, the P/E ratio is 15.51. StockValueFinder utilizes a discipline of preferring a P/E of 15 or lower to ensure investors are not overpaying for growth. Because 15.51 is above this threshold, the P/E valuation test DID NOT PASS.
To understand valuation in context, consider this: A company with a P/E of 8 may be more value-oriented than a company with a P/E of 40, assuming the business quality is sound. While a higher P/E can sometimes be justified by rapid growth expectations, a disciplined researcher looks for a balance between price and the underlying earnings power. In DVA's case, the current price represents a slightly higher multiple than the preferred valuation ceiling.
Moving Average Trend and Entry Timing
While the fundamental metrics above focus on the "quality" of the business, technical indicators like moving averages focus on "momentum" or market sentiment.
The moving average signal for DaVita HealthCare Partners Inc is currently a STRONG BUY TREND. This indicates that, in terms of recent price action, the stock has been trending upward. However, it is vital to distinguish between a trend and quality. A strong buy trend does not mean the company's fundamentals have improved; it simply means that market participants are currently willing to pay higher prices for the stock.
Regarding entry and risk management
– **Entry Signal:** N/A – **Limit Buy Idea:** N/A – **Pullback Zone:** N/A – **Risk Stop / Trend Risk Level:** N/A
These fields are marked as "N/A," meaning no specific technical entry or exit levels were provided in this data set. In professional research, these levels serve as educational reference points to help traders manage their discipline, rather than being direct orders to buy or sell.
Overall Financial Strengths and Weaknesses
In summary, the financial profile of DaVita HealthCare Partners Inc presents a dichotomy between price momentum and fundamental stability.
**Strengths:** – **Earnings Consistency:** The company passed the EPS strength test, suggesting that despite other challenges, its ability to generate earnings per share has remained consistent according to the system's parameters. – **Price Momentum:** The "Strong Buy Trend" indicates positive short-term market sentiment and upward price movement.
**Weaknesses:** – **Capital Inefficiency:** An ROIC of 5.32% is below the preferred 10% threshold, indicating suboptimal use of invested capital. – **Debt Burden:** Both interest coverage and debt payback failed their respective tests, pointing to significant long-term debt obligations and potential solvency risks. – **Valuation:** The P/E ratio of 15.51 sits outside the preferred valuation range, suggesting the stock may not be trading at a deep value discount.
Risks and Limitations
Investors must recognize that quantitative models are based on historical and current data, which cannot predict future market shifts or unexpected economic events. The primary risks identified in this research for DVA include high leverage (debt) and lower-than-ideal capital efficiency. In a rising interest rate environment or an economic contraction, companies with high debt payback periods and low interest coverage are often more vulnerable to volatility.
Furthermore, the "Strong Buy Trend" is a technical signal that can change rapidly as market incentives shift. Relying solely on momentum without addressing the underlying fundamental failures (ROIC, Debt, P/E) can lead to significant uncertainty.
Educational Conclusion
The study of DaVita HealthCare Partners Inc serves as an excellent lesson in why multi-factor analysis is necessary. If a researcher only looked at the moving average, they might see a "Strong Buy." However, by applying the StockValueFinder filters, we see a much more complex picture: a company with consistent earnings but significant challenges regarding debt management and capital efficiency.
A disciplined approach requires looking past the price trend to evaluate whether the underlying business is generating sufficient returns on its capital and maintaining a safe margin of safety through interest coverage and manageable debt levels.
This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.
Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings
Linus Lee specializes in interpreting financial data, evaluating investment opportunities, and explaining complex market information in clear, practical language. His research focuses on fundamental stock analysis, dividend-paying equities, exchange-traded funds (ETFs), income strategies, valuation metrics, historical performance, portfolio risk, and long-term investment considerations.